Controlled human exposures to ambient pollutant particles in susceptible populations.

dc.contributor.author

Huang, Yuh-Chin T

dc.contributor.author

Ghio, Andrew J

dc.date.accessioned

2021-01-26T23:09:52Z

dc.date.available

2021-01-26T23:09:52Z

dc.date.issued

2009-01

dc.date.updated

2021-01-26T23:09:52Z

dc.description.abstract

Epidemiologic studies have established an association between exposures to air pollution particles and human mortality and morbidity at concentrations of particles currently found in major metropolitan areas. The adverse effects of pollution particles are most prominent in susceptible subjects, including the elderly and patients with cardiopulmonary diseases. Controlled human exposure studies have been used to confirm the causal relationship between pollution particle exposure and adverse health effects. Earlier studies enrolled mostly young healthy subjects and have largely confirmed the capability of particles to cause adverse health effects shown in epidemiological studies. In the last few years, more studies involving susceptible populations have been published. These recent studies in susceptible populations, however, have shown that the adverse responses to particles appear diminished in these susceptible subjects compared to those in healthy subjects. The present paper reviewed and compared control human exposure studies to particles and sought to explain the "unexpected" response to particle exposure in these susceptible populations and make recommendations for future studies. We found that the causes for the discrepant results are likely multifactorial. Factors such as medications, the disease itself, genetic susceptibility, subject selection bias that is intrinsic to many controlled exposure studies and nonspecificity of study endpoints may explain part of the results. Future controlled exposure studies should select endpoints that are more closely related to the pathogenesis of the disease and reflect the severity of particle-induced health effects in the specific populations under investigation. Future studies should also attempt to control for medications and genetic susceptibility. Using a different study design, such as exposing subjects to filtered air and ambient levels of particles, and assessing the improvement in biological endpoints during filtered air exposure, may allow the inclusion of higher risk patients who are likely the main contributors to the increased particle-induced health effects in epidemiological studies.

dc.identifier

1476-069X-8-33

dc.identifier.issn

1476-069X

dc.identifier.issn

1476-069X

dc.identifier.uri

https://hdl.handle.net/10161/22247

dc.language

eng

dc.publisher

Springer Science and Business Media LLC

dc.relation.ispartof

Environmental health : a global access science source

dc.relation.isversionof

10.1186/1476-069x-8-33

dc.subject

Humans

dc.subject

Lung Diseases, Obstructive

dc.subject

Myocardial Ischemia

dc.subject

Pulmonary Heart Disease

dc.subject

Air Pollutants

dc.subject

Risk Factors

dc.subject

Atmosphere Exposure Chambers

dc.subject

Air Pollution

dc.subject

Environmental Exposure

dc.subject

Population

dc.subject

Particulate Matter

dc.subject

Controlled Clinical Trials as Topic

dc.title

Controlled human exposures to ambient pollutant particles in susceptible populations.

dc.type

Journal article

pubs.begin-page

33

pubs.issue

1

pubs.organisational-group

School of Medicine

pubs.organisational-group

Medicine, Pulmonary, Allergy, and Critical Care Medicine

pubs.organisational-group

Duke

pubs.organisational-group

Medicine

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

pubs.volume

8

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Controlled human exposures to ambient pollutant particles in susceptible populations.pdf
Size:
314.02 KB
Format:
Adobe Portable Document Format